Soren, O., Brinch, K.S., Patel, D., Liu, Y., Liu, A., Coates, A., et al., Antimicrob
Pharmacol.,1987253 EOF306 EOF 128
(2023) 42:e112814
That is a clean model if you dislike subscriptions
What this means for clinical research sites: The patient population for GLP-1 trials is enormous and largely untapped
Semaglutide or tirzepatide may be appropriate if you: Have a body mass index (BMI) in the range qualifying for medical weight management Are committed to lifestyle changes (diet, physical activity, behavior) Do not have contraindications such as certain pancreatic or gallbladder disorders Have no allergies to the medications or excipients These drugs are not recommended in pregnancy, while breastfeeding, or in people with certain medical conditions unless cleared by a physician